C1Q NEPHROPATHY

This adverse event was reported 6 times

C1Q NEPHROPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TALIMOGENE LAHERPAREPVEC 1 0.0006
1 NITROGLYCERIN 1 0.0000
2 TACROLIMUS OINTMENT 0.1% 2 0.0000
3 TACROLIMUS EXTENDED-RELEASE CAPSULES 2 0.0000
4 MYCOPHENOLATE MOFETIL 2 0.0000
5 FLUCONAZOLE 1 0.0000
6 TACROLIMUS 2 0.0000
7 SULFAMETHOXAZOLE AND TRIMETHOPRIM 1 0.0000
8 BACLOFEN 1 0.0000
9 AZATHIOPRINE 1 0.0000
See all drugs enriched for association with C1Q NEPHROPATHY